MedTrace Logo

Effects of Omega-3 Fatty Acids on Bone and Frailty

NCT00634686 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2009-02-02

No results posted yet for this study

Summary

The purpose of this study is to examine the effects of essential fatty acid (EFA) supplementation on bone metabolism and frailty in postmenopausal women. The overall hypothesis is that EFA supplementation, via its immunoregulatory and anti-inflammatory activity, will decrease bone turnover, decrease prostaglandins and cytokines associated with bone metabolism and frailty, and change physical outcome measures associated with frailty in postmenopausal women with low bone mass and frailty.

Conditions

Interventions

DIETARY_SUPPLEMENT

DHA/EPA

1.2 gram capsule daily for 6 months

DIETARY_SUPPLEMENT

Placebo capsule

daily for 6 months

DIETARY_SUPPLEMENT

Calcium with vitamin D

1000 mg of calcium with 1000 IU vitamin D daily for 6 months

Sponsors & Collaborators

  • University of Connecticut

    collaborator OTHER

  • Donaghue Medical Research Foundation

    lead OTHER

Principal Investigators

  • Anne Kenny, MD · University of Connecticut Center on Aging

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00634686 on ClinicalTrials.gov